Dr. Amaka Eneanya spoke recently on NPR’s Weekend Edition Saturday about the Trump Administration’s strategy for “Advancing American Kidney Health.” Dr. Eneanya is an assistant professor of medicine at the Hospital of the University of Pennsylvania, a practicing nephrologist, and an ASN member (@AmakaEMD).
Dr. Amaka Eneanya spoke recently on NPR’s Weekend Edition Saturday about the Trump Administration’s strategy for “Advancing American Kidney Health.” Dr. Eneanya is an assistant professor of medicine at the Hospital of the University of Pennsylvania, a practicing nephrologist, and an ASN member (@AmakaEMD
).
She describes the push for home dialysis and details of how the process works, mentioning that countries such as Guatemala, Mexico, and Hong Kong have the majority of their patients using some type of home dialysis. “It’s quite a burden to do things the way that [we] have been doing, which is most of the patients going to dialysis or receiving dialysis in a facility,” said Dr. Eneanya. The new initiative advocates for 80% of patients with end-stage kidney disease to be on a home dialysis modality or to receive a transplant.
Additionally, the initiative aims to double the number of kidneys available for transplant and will incentivize donors by “paying them for lost wages and child care that they may have to use after doing a surgery… I think actually educating donors and providing these incentives will really make a difference,” said Dr. Eneanya.
Please listen to the full interview on NPR.org .
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory